Markus Flesch

3.3k total citations
58 papers, 2.7k citations indexed

About

Markus Flesch is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Markus Flesch has authored 58 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cardiology and Cardiovascular Medicine, 29 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Markus Flesch's work include Cardiac electrophysiology and arrhythmias (17 papers), Receptor Mechanisms and Signaling (17 papers) and Renin-Angiotensin System Studies (11 papers). Markus Flesch is often cited by papers focused on Cardiac electrophysiology and arrhythmias (17 papers), Receptor Mechanisms and Signaling (17 papers) and Renin-Angiotensin System Studies (11 papers). Markus Flesch collaborates with scholars based in Germany, United States and Netherlands. Markus Flesch's co-authors include Michael Böhm, Michael Böhm, Erland Erdmann, Robert H. G. Schwinger, Stephan Rosenkranz, Michael Südkamp, Bodo Cremers, Heiko Kilter, Frank Schiffer and Andreas Schwarz and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Markus Flesch

56 papers receiving 2.6k citations

Peers

Markus Flesch

CCM

PHYSI

PFM

SURGE

Hideharu Hayashi Japan

Tiziana Bachetti Italy

Shunji Hayashidani Japan

Tomohiro Osanai Japan

Hozuka Akita Japan

Shigeru Motomura Japan

P. Rösen Germany

Cynthia A. Carnes United States

Pierre Sicard France

Hazel Lum United States

Hideharu Hayashi Japan

Markus Flesch

1.1k ×0.7

CCM

1.5k ×1.1

542 ×1.6

PHYSI

483 ×1.6

PFM

298 ×1.1

SURGE

Citations per year, relative to Markus Flesch Markus Flesch (= 1×) peers Hideharu Hayashi

Countries citing papers authored by Markus Flesch

Since Specialization

Citations

This map shows the geographic impact of Markus Flesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Flesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Flesch more than expected).

Fields of papers citing papers by Markus Flesch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Flesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Flesch. The network helps show where Markus Flesch may publish in the future.

Co-authorship network of co-authors of Markus Flesch

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Flesch. A scholar is included among the top collaborators of Markus Flesch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Flesch. Markus Flesch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Müller‐Ehmsen, Jochen, Daniela A. Braun, Thomas Schneider, et al.. (2008). Decreased number of circulating progenitor cells in obesity: beneficial effects of weight reduction. European Heart Journal. 29(12). 1560–1568. 97 indexed citations

Pfister, Roman, Volker Burst, H. Geißler, et al.. (2006). Loss of β1D-integrin function in human ischemic cardiomyopathy. Basic Research in Cardiology. 102(3). 257–264. 21 indexed citations

Plenz, Gabriele, Michael Erren, Thomas Wichter, et al.. (2002). The interleukin-6/interleukin-6-receptorsystem is activated in donor hearts. Journal of the American College of Cardiology. 39(9). 1508–1512. 70 indexed citations

Schiffmann, Holger, et al.. (2002). Effects of different inotropic interventions on myocardial function in the developing rabbit heart. Basic Research in Cardiology. 97(1). 76–87. 10 indexed citations

Flesch, Markus, Stephan Rosenkranz, E Erdmann, & Michael Böhm. (2001). Alcohol and the risk of myocardial infarction. Basic Research in Cardiology. 96(2). 128–135. 69 indexed citations

Flesch, Markus & Erland Erdmann. (2001). Na+ Channel Activators as Positive Inotropic Agents for the Treatment of Chronic Heart Failure. Cardiovascular Drugs and Therapy. 15(5). 379–386. 13 indexed citations

Maack, Christoph, Bodo Cremers, Markus Flesch, et al.. (2000). Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium. British Journal of Pharmacology. 130(5). 1131–1139. 83 indexed citations

Flesch, Markus, Heiko Kilter, Bodo Cremers, et al.. (1999). Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite. Journal of the American College of Cardiology. 33(4). 1062–1070. 58 indexed citations

Suedkamp, Michael, Helmut Eiffert, Markus Flesch, et al.. (1999). Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA. American Heart Journal. 138(2). 269–272. 18 indexed citations

10.

Teisman, Ard, Yigal M. Pinto, Hendrik Buikema, et al.. (1998). Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats. Journal of Hypertension. 16(12). 1759–1765. 26 indexed citations

11.

Bäumer, Anselm T., Markus Flesch, Heiko Kilter, Kenneth D. Philipson, & Michael Böhm. (1998). Overexpression of the Na+-Ca2+Exchanger Leads to Enhanced Inotropic Responsiveness to Na+-Channel Agonist without Sarcoplasmic Reticulum Protein Changes in Transgenic Mice. Biochemical and Biophysical Research Communications. 249(3). 786–790. 17 indexed citations

12.

Rosenkranz, Stephan, Georg Nickenig, Markus Flesch, et al.. (1997). Cardiac angiotensin II receptors: studies on functional coupling in Sprague-Dawley rats and TGR(αMHC-hAT1) transgenic rats. European Journal of Pharmacology. 330(1). 35–46. 10 indexed citations

13.

Cremers, Bodo, Markus Flesch, Michael Südkamp, & Michael Böhm. (1997). Effects of the Novel T-Type Calcium Channel Antagonist Mibefradil on Human Myocardial Contractility in Comparison with Nifedipine and Verapamil. Journal of Cardiovascular Pharmacology. 29(5). 692–696. 25 indexed citations

14.

Flesch, Markus, et al.. (1996). Biology of Cardiac Overload. European Heart Journal. 17(suppl 2). 3–3. 8 indexed citations

15.

Flesch, Markus, Robert H. G. Schwinger, Petra Schnabel, et al.. (1996). Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy. Journal of Molecular Medicine. 74(6). 321–332. 92 indexed citations

16.

Flesch, Markus, et al.. (1996). Changes in beta-adrenoceptors and G-proteins during the transition from cardiac hypertrophy to heart failure. Journal of Cardiac Failure. 2(4 Suppl). S35–S43. 7 indexed citations

17.

Lenz, Olaf, Hans Bernhard Schmid, Heiko Kilter, et al.. (1995). Effects of angiotensin II and angiotensin-converting enzyme inhibitors on human myocardium. European Journal of Pharmacology. 294(1). 17–27. 8 indexed citations

18.

Kilter, Heiko, Olaf Lenz, Karl La Rosée, et al.. (1995). Evidence against a role of nitric oxide in the indirect negative inotropic-effect of M-cholinoceptor stimulation in human ventricular myocardium. Naunyn-Schmiedeberg s Archives of Pharmacology. 352(3). 308–312. 15 indexed citations

19.

Flesch, Markus, Yon Ko, Claudia Seul, et al.. (1995). Effects of TCV-116 and CV-11974 on angiotensin II-induced responses in vascular smooth muscle cells. European Journal of Pharmacology Molecular Pharmacology. 289(2). 399–402. 12 indexed citations

20.

Flesch, Markus, Agapios Sachinidis, Y. Ko, K Kraft, & H. Vetter. (1994). Plasma lipids and lipoproteins and essential hypertension. Journal of Molecular Medicine. 72(12). 944–950. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact